ABSTRACT
Introduction
The most common cause of Subarachnoid Hemorrhage is trauma. Among the spontaneous causes of SAH, the rupture of intracranial aneurysms represents about 75 to 80%. Amongst other etiologies are arteriovenous malformations, dural sinus thrombosis, vasculitis, cerebral artery dissection and clotting disorders 5 .
Relationship between intracranial hemorrhage and the use of oral anticoagulants is well established by literature, mainly intraparenchymal hemorhages. However, SAH is a rare event in those cases, and in order to assign it to the use of anticoagulants it is necessary to exclude the existence of aneurysms or other vascular disorders by taking tests such as neuraxis MRI or cerebral angiography 2 .
The objective of this article is to report an spontaneous SAH case associated to the use of warfarin and accomplish a short review about the subject.
Discussion
Over 5-12% of intracranial bleeding are related to oral anticoagulants, the most lethal complication of their use. Intracranial bleeding can be divided into intraparenchymal, subdural / epidural and subarachnoid. Seventy percent of the cases are intraparenchymal, whose location in descending order of frequency is: in deep regions of the brain, cerebral hemispheres, cerebellum and brain stem. However, the relationship with SAH is a rare condition 8 .
Olsen et al. have shown that there is no increased risk of SAH associated with the use of oral anticoagulants 7 . On the other hand, more recent studies have suggested this association mainly with combined vitamin K antagonists, evidenced by Risselada et al. and Garcia-Rodriguez 4, 9 . Other authors have even pointed INR > 3.5 in patients under warfarin intake presenting intracranial haemorrhage, a two-fold risk of fatal event 10 .
The use of prothrombin complex concentrate associated with
Case Report
Female, 50 years, hypertensive, submitted to valvuloplasty surgery on May, 2011 and since then in use of Warfarin, presented on May, 2012 with a severe headache, described as "the worst of her life", associated to paresis in the left body. Admited to the hospital in GCS 15, with neck stiffness, hemiparesia in the left side and nasolabial sulcus shift to the right.
The head CT (computed tomography) showed SAH Fisher II, without sign of ischemia. Laboratorial exams showed INR of 10. AngioCT did not show aneurism. The patient was taken to ICU, and anticoagulant was suspended, the INR was corrected with fresh plasma and K vitamin and neuroprotective measures were taken. Arteriography also did not reveal aneurism.
During hospitalization she presented a bilateral pulmonary embolism and cerebral salt-wasting, both properly corrected. After one month of hospitalization the patient was discharged in GCS 15, asymptomatic, with normalized INR and reintroduction of Warfarin. fresh plasma and vitamin K also has shown good results in the literature as an approach for reversal of warfarin in cases of intracranial hemorrhage (ICH). However, as shown by Huttner, the time of reversal therapy does not seem to be related to increased bruising, being possible to occur after complete reversal of the INR with administration of frozen plasma and vitamin K. There was also no evidence of increased mortality or rebleeding in cases that restarted the use of warfarin after intracranial hemorrhage in high-risk group for thrombosis 1, 3, 6, 11 .
The initial volume of intracranial hemorrhage and its expansion, level of consciousness and site of bleeding are some of the factors related to the prognosis of the patient. In a multivariate analysis of mortality predictors were included INR > 3, intraventricular hemorrhage and massive SAH 3 . In another study, in addition to the volume of the ICH and the low level of consciousness, hyperglycemia was also considered as a factor of prognosis worsening because of the possible effect of swelling and hematoma enlargement in the area around the dead cells 6 .
Conclusion
Intracranial hemorrhage associated to use of oral anticoagulants are the leading cause of death in these patients, however among them the isolated SAH is a rare event and therefore with few reports in the literature. The INR reversal therapy with the use of prothrombin concentrate, fresh frozen plasma and vitamin K has been adopted in the approach of these patients, although there is no consensus in literature that the time of reversal therapy influences the increasing of bleeding or the prognosis of patients.
